Paul H. Lange, MD, FACS

Paul H. Lange, MD, FACS
is chairman emeritus of the Urology department at
the University of Washington. He received his B.A. from Lawrence
College and his M.D. from Washington University Medical School.
He subsequently received clinical and research training at the National
Institutes of Health, Duke University, and the University of Minnesota.
He has served on many editorial boards, including that of the New
England Journal of Medicine, and is a member of many professional
and honorary societies. Dr. Lange is internationally recognized
for his clinical and research work in a variety of genitourinary
cancers, including prostate, testis, bladder and kidney, and he
has authored more than 400 published articles, chapters, and books
on oncology. Of particular note, he helped develop serum markers
for testis (AFP, HCG) and prostate (PSA) cancers. Dr. Lange currently
directs a large clinical practice in urologic oncology and is co-director
of the department's experimental laboratories in genitourinary oncology
which focus on molecular studies in prostate cancer. In that capacity
he serves as principal investigator on a Program Project grant and
the Pacific Northwest Prostate Cancer SPORE. He is currently serving
as a member of the American Board of Urology.